12:32 PM EDT, 03/11/2024 (MT Newswires) -- Merck ( MRK ) said Monday it has completed the acquisition of Harpoon Therapeutics ( HARP ) .

Harpoon is now wholly owned by Merck ( MRK ), and its common stock is no longer publicly traded on Nasdaq, the company said.

Merck ( MRK ) said it has recorded a non-tax deductible charge of roughly $650 million, as part of the acquisition.

Price: 122.94, Change: -0.56, Percent Change: -0.45